Organigram (NASDAQ:OGI) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Organigram (NASDAQ:OGI) issued its earnings results on Tuesday. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.02), Zacks reports. Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%.

Organigram Price Performance

NASDAQ OGI opened at $1.73 on Tuesday. The company has a fifty day moving average of $1.56 and a two-hundred day moving average of $1.67. The company has a market capitalization of $218.26 million, a PE ratio of -4.55 and a beta of 1.00. Organigram has a 1 year low of $1.31 and a 1 year high of $2.91.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.